Previous Article | Next Article 
Antimicrobial Agents and Chemotherapy, July 2003, p. 2082-2087, Vol. 47, No. 7
0066-4804/03/$08.00+0 DOI: 10.1128/AAC.47.7.2082-2087.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
Burkholderia pseudomallei Class A ß-Lactamase Mutations That Confer Selective Resistance against Ceftazidime or Clavulanic Acid Inhibition
Chanwit Tribuddharat,1 Richard A. Moore,2 Patricia Baker,2 and Donald E. Woods2*
Department of Microbiology, Mahidol University, Bangkok 10700, Thailand,1
Department of Microbiology and Infectious Diseases, University of Calgary Health Sciences Centre, Calgary, Alberta, Canada T2N 4N122
Received 25 October 2002/
Returned for modification 24 January 2003/
Accepted 29 March 2003
Burkholderia pseudomallei, the causative agent of melioidosis, is inherently resistant to a variety of antibiotics including aminoglycosides, macrolides, polymyxins, and ß-lactam antibiotics. Despite resistance to many ß-lactams, ceftazidime and ß-lactamase inhibitor-ß-lactam combinations are commonly used for treatment of melioidosis. Here, we examine the enzyme kinetics of ß-lactamase isolated from mutants resistant to ceftazidime and clavulanic acid inhibition and describe specific mutations within conserved motifs of the ß-lactamase enzyme which account for these resistance patterns. Sequence analysis of regions flanking the B. pseudomallei penA gene revealed a putative regulator gene located downstream of penA. We have cloned and sequenced the penA gene from B. mallei and found it to be identical to penA from B. pseudomallei.
* Corresponding author. Mailing address: Department of Microbiology and Infectious Diseases, University of Calgary Health Sciences Centre, 3330 Hospital Dr. N.W., Calgary, Alberta, Canada T2N 4N1. Phone: (403) 220-2564. Fax: (403) 270-5520. E-mail:
woods{at}ucalgary.ca.
Antimicrobial Agents and Chemotherapy, July 2003, p. 2082-2087, Vol. 47, No. 7
0066-4804/03/$08.00+0 DOI: 10.1128/AAC.47.7.2082-2087.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Sam, I-C., See, K. H., Puthucheary, S. D.
(2009). Variations in Ceftazidime and Amoxicillin-Clavulanate Susceptibilities within a Clonal Infection of Burkholderia pseudomallei. J. Clin. Microbiol.
47: 1556-1558
[Abstract]
[Full Text]
-
Holden, M. T. G., Seth-Smith, H. M. B., Crossman, L. C., Sebaihia, M., Bentley, S. D., Cerdeno-Tarraga, A. M., Thomson, N. R., Bason, N., Quail, M. A., Sharp, S., Cherevach, I., Churcher, C., Goodhead, I., Hauser, H., Holroyd, N., Mungall, K., Scott, P., Walker, D., White, B., Rose, H., Iversen, P., Mil-Homens, D., Rocha, E. P. C., Fialho, A. M., Baldwin, A., Dowson, C., Barrell, B. G., Govan, J. R., Vandamme, P., Hart, C. A., Mahenthiralingam, E., Parkhill, J.
(2009). The Genome of Burkholderia cenocepacia J2315, an Epidemic Pathogen of Cystic Fibrosis Patients. J. Bacteriol.
191: 261-277
[Abstract]
[Full Text]
-
Falade, O. O., Antonarakis, E. S., Kaul, D. R., Saint, S., Murphy, P. A.
(2008). Beware of First Impressions. NEJM
359: 628-634
[Full Text]
-
Cheng, A. C., Currie, B. J.
(2005). Melioidosis: Epidemiology, Pathophysiology, and Management. Clin. Microbiol. Rev.
18: 383-416
[Abstract]
[Full Text]
-
Keith, K. E., Oyston, P. C., Crossett, B., Fairweather, N. F., Titball, R. W., Walsh, T. R., Brown, K. A.
(2005). Functional Characterization of OXA-57, a Class D {beta}-Lactamase from Burkholderia pseudomallei. Antimicrob. Agents Chemother.
49: 1639-1641
[Abstract]
[Full Text]